“Our goal is to accelerate the Botanical Synthesis movement that our team has wholly dedicated themselves to – driving forward innovation, our...
Read MoreBHSC NOVEMBER NEWSLETTER
Dear subscriber,
December is upon us (Happy Thanksgiving to our US community!), and our R+D and Business Development/Marketing teams are pushing hard to hit our major 2021 Strategic Milestones. As we ramp up our external messaging in our Nutraceutical and Cannabis verticals, you will see more Bioharvest news in the media, but we will also continue to summarize our corporate and marketing highlights in our regular newsletter.
As we continue to build BioHarvest Sciences into a commercial machine, our followers can expect to see multiple major announcements, so stay tuned!
BHSC November News Releases
Nov 22, 2021 – Our new 20 Ton facility has formally obtained GMP certification from Israel’s Ministry of Health! VINIA® production will transfer to the new facility, which gives us the capacity to supply multiple global markets with over 20 tons/year of VINIA® as well as the other polyphenol-based products in BioHarvest’s innovation pipeline. In an interview with Proactive Investors, CEO Ilan Sobel commented “”We now have the critical oxygen that will allow us to grow based on demand and not be constrained based on supply.”
BIOHARVEST SCIENCES NEW 20 TONS PER YEAR FACTORY OBTAINS THE GMP (GOOD MANUFACTURING PRACTICES) CERTIFICATION FROM THE ISRAELI MINISTRY OF HEALTH – Bioharvest
Nov 15, 2021 – We announced that our research has provided more support for the anti-oxidation structure/function claims for VINIA®. As stated by Yochi Hagay, BioHarvest CTO, “Cholesterol damages the cardiovascular functioning when it gets oxidized. The unique composition of VINIA® (that includes a complex of polyphenols with Piceid resveratrol) reduces the oxidation of the lipids as well as improves blood flow.
NEW RESEARCH ANALYSIS SHOWS VINIA® REDUCES OXIDATION OF LDL-CHOLESTEROL TO SUPPORT CARDIOVASCULAR IMPROVED FUNCTIONING – Bioharvest
Senior BioTech Executives join the BioHarvest Team
We have proudly announced the addition of two impressive global executives, both of whom have grown life-science based BioTech businesses into major global brands. Adding these highly qualified executives will help us achieve our BioTech Vision for the company:
Steven Lehrer – Mr. Lehrer’s 40 years of Biotech experience enhances the board of advisors with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D.
BIOHARVEST SCIENCES INC. APPOINTS STEVEN LEHRER TO ITS BOARD OF ADVISORS – Bioharvest
David Tsur – During his career, Mr. Tsur has been responsible for generating sales of more than $1 billion (USD) for companies operating in more than 20 countries. He has also built multiple strategic relationships with U.S. and European companies while leading these companies through the innovation processes.
BIOHARVEST SCIENCES INC. ANNOUNCES APPOINTMENT OF DAVID TSUR TO BOARD OF DIRECTORS – Bioharvest
BHSC Media Coverage
Marijuana Venture Magazine thought Biofarming “sounded like science fiction”, so they interviewed Ilan and are now featuring that interview across 4 pages in their new December version. This cannabis industry magazine is available on newsstands, but the digital version is available for purchase. For a free copy of the article, contact justin@bioharvest.com.
Extraction Magazine interviewed Ilan Sobel as part of their “Voices of Disruption” series, titled “Sustainably Biofarming Cannabinoids”. Read article
Weed World posted an in-depth article in the “Research and Development” section of Issue 153, titled “The Reservoir Revolution.” For a free copy of the article, contact justin@bioharvest.com. Subscription article
Proactive Investors interviewed Ilan Sobel on the importance of the new 20 ton VINIA facility coming online to supply global growth.
BioHarvest Sciences factory receives GMP certification from Israeli Ministry of Health – YouTube
Upcoming Conferences
Our Blog
Are depleted soils depleting the benefits of fruits and vegetables?
By Dr. Brian Cornblatt Over the past 50 years there has been a paradigm shift in dietary preferences. The proverbial meat and potatoes —once...
Read MoreAbout BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. BioHarvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals – nutraceutical health and wellness products such as dietary supplements, and development of plant cell-based Active Pharmaceutical Ingredients (API’s) that focus on specific medical indications.